Select Page
FDA Approval: First Injectable PrEP for HIV

FDA Approval: First Injectable PrEP for HIV

The U.S. Food and Drug Administration (FDA) has given approval to start producing ViiV Healthcare’s cabotegavir, the first and only long-acting injectable pre-exposure prophylactic (PrEP) to reduce the risk of sexually acquired HIV-1. HIV-1 affects nearly 38 million...
FDA Approves Thermo Fisher’s CDx Cancer Tissue Test

FDA Approves Thermo Fisher’s CDx Cancer Tissue Test

The U.S. Food and Drug Administration (FDA) has granted premarket approval for Thermo Fisher’s Oncomine Dx Target Test as a companion diagnostic (CDx) developed to help identify non-small cell lung cancer (NSCLC) patients. Lung cancer is the leading cause of...